YU70995A - Postupak za prečišćavanje i izdvajanje 2'-deoksi-2',2'-difluoronukleozida - Google Patents

Postupak za prečišćavanje i izdvajanje 2'-deoksi-2',2'-difluoronukleozida

Info

Publication number
YU70995A
YU70995A YU70995A YU70995A YU70995A YU 70995 A YU70995 A YU 70995A YU 70995 A YU70995 A YU 70995A YU 70995 A YU70995 A YU 70995A YU 70995 A YU70995 A YU 70995A
Authority
YU
Yugoslavia
Prior art keywords
formula
mixture
group
purifying
isolating
Prior art date
Application number
YU70995A
Other languages
English (en)
Other versions
YU49446B (sh
Inventor
Ta-Sen Chou
Laurie Michelle Poteet
Douglas Patton Kjell
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23335711&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU70995(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU70995A publication Critical patent/YU70995A/sh
Publication of YU49446B publication Critical patent/YU49446B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Postupak za prečišćavanje i izdvajanje beta-anomerom obogaćenog nukleozida koji obuhvata: a) obezbedjivanje smeše koja sadrži R" i beta-anomerom obogaćen nukleozid formule u kojoj je svako X nezavisno odabrano od hidroksi zaštitnih grupa, a R je nukleobaza formule gde je W amino zaštitna grupa; i R" je nukleobaza formule gde je W amino zaštitna grupa ili vodonik; u rastvaraču sa visokom tačkom ključanja; b) razblaživanje smeše organskim rastvaračem odabranim iz grupe koja se sastoji od etara, estara i nitrila; c) dodavanje razblažene reakcione smeše vodenom rastvoru kiseline; i d) održavanje tako dobijene kiselinske smeše na temperaturi od 70В°C do 100В°C sve dotle dok se proizvod iz formule IB, gde je W sada W', nije istaložio.
YU70995A 1994-11-17 1995-11-13 Postupak za prečišćavanje i izdvajanje 2'-deoksi-2', 2'-difluoronukleozida YU49446B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/340,972 US5606048A (en) 1992-06-22 1994-11-17 Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides

Publications (2)

Publication Number Publication Date
YU70995A true YU70995A (sh) 1998-09-18
YU49446B YU49446B (sh) 2006-03-03

Family

ID=23335711

Family Applications (1)

Application Number Title Priority Date Filing Date
YU70995A YU49446B (sh) 1994-11-17 1995-11-13 Postupak za prečišćavanje i izdvajanje 2'-deoksi-2', 2'-difluoronukleozida

Country Status (34)

Country Link
US (1) US5606048A (sh)
EP (1) EP0712860B1 (sh)
JP (1) JPH10509170A (sh)
KR (1) KR100424990B1 (sh)
CN (1) CN1044119C (sh)
AR (1) AR001045A1 (sh)
AT (1) ATE210142T1 (sh)
AU (1) AU702588B2 (sh)
BG (1) BG62737B1 (sh)
BR (1) BR9509904A (sh)
CA (1) CA2205350C (sh)
CO (1) CO4600741A1 (sh)
CZ (1) CZ292013B6 (sh)
DE (1) DE69524365T2 (sh)
DK (1) DK0712860T3 (sh)
ES (1) ES2164745T3 (sh)
HU (1) HU219019B (sh)
IL (1) IL115854A (sh)
MX (1) MX9703548A (sh)
MY (1) MY115183A (sh)
NO (1) NO308305B1 (sh)
NZ (1) NZ296712A (sh)
PE (1) PE50196A1 (sh)
PL (1) PL182052B1 (sh)
PT (1) PT712860E (sh)
RO (1) RO118296B1 (sh)
RU (1) RU2161622C2 (sh)
SI (1) SI0712860T1 (sh)
SK (1) SK283160B6 (sh)
TW (1) TW377356B (sh)
UA (1) UA53614C2 (sh)
WO (1) WO1996016072A1 (sh)
YU (1) YU49446B (sh)
ZA (1) ZA959321B (sh)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) * 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
MY164523A (en) * 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
EA007867B1 (ru) * 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Композиции для лечения флавивирусных и пестивирусных инфекций и способы их применения
US7435755B2 (en) * 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
US7176237B2 (en) * 2002-01-15 2007-02-13 The Trustees Of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
CN101172993A (zh) * 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
AP2005003213A0 (en) * 2002-06-28 2005-03-31 Univ Cagliari 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
US7608600B2 (en) * 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
WO2004041203A2 (en) * 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US7824851B2 (en) * 2002-11-15 2010-11-02 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
CA2509687C (en) * 2002-12-12 2012-08-14 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides
WO2006000922A2 (en) * 2004-06-23 2006-01-05 Idenix (Cayman) Limited 5-aza-7-deazapurine derivatives for treating infections with flaviviridae
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
US20060173174A1 (en) * 2004-12-08 2006-08-03 Anne-Ruth Born Difluoronucleosides and process for preparation thereof
WO2006070985A1 (en) 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. METHOD FOR THE PREPARATION OF 2#-DEOXY-2#,2#-DIFLUOROCYTIDINE
AU2005320374B2 (en) * 2004-12-30 2009-01-08 Hanmi Science Co., Ltd. Method for the preparation of 2'-deoxy-2',2'-difluorocytidine
AU2005328519B2 (en) * 2005-03-04 2012-03-01 Fresenius Kabi Oncology Limited Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-D-ribofuranosyl nucleosides
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
EP1891087A4 (en) * 2005-06-03 2008-07-30 Scinopharm Taiwan Ltd PROCESS FOR PRODUCING ALPHA-ANOMER ENRICHED 2-DEOXY-2,2-DIFLUORO-D-RIBOFURANOSYL SULFONATE AND USE THEREOF FOR THE PRODUCTION OF BETA NUCLEOSIDE
AU2011202539B2 (en) * 2005-06-03 2012-07-05 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
EP1940859A1 (en) 2005-10-28 2008-07-09 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride
CA2634749C (en) * 2005-12-23 2014-08-19 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
EP1994042A4 (en) * 2006-02-06 2009-03-18 Reddys Lab Ltd Dr PREPARATION OF GEMCITABINE
US7714012B2 (en) * 2006-11-17 2010-05-11 Trustees Of Dartmouth University Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
WO2008064132A2 (en) * 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
JP5349342B2 (ja) * 2007-03-23 2013-11-20 ドンウ シンテック カンパニー リミテッド ２’−デオキシ−２’，２’−ジフルオロシチジンの製造方法
CN100475832C (zh) * 2007-05-31 2009-04-08 南京卡文迪许生物工程技术有限公司 一种新颖的高立体选择性合成吉西他滨工艺及中间体
WO2009023845A2 (en) * 2007-08-15 2009-02-19 The Board Of Regents Of The University Of Texas System Combination therapy with synthetic triterpenoids and gemcitabine
EP2050757A1 (en) 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain vehicles, installations and methods
TW201216958A (en) * 2008-01-11 2012-05-01 Reata Pharmaceuticals Inc Synthetic triterpenoids and methods of use in the treatment of disease
KR101735807B1 (ko) 2008-04-18 2017-05-15 리타 파마슈티컬스 잉크. Ｃ-17에 아미노 및 기타 변형을 갖는 올레아놀산 유도체를 포함하는 항산화 염증 조절제
WO2009146216A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals. Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CA2721666C (en) 2008-04-18 2017-05-23 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives
MX2010011437A (es) 2008-04-18 2010-12-20 Reata Pharmaceuticals Inc Moduladores antioxidantes de inflamacion: derivados del acido oleanolico con saturacion en el anillo c.
TW201006474A (en) 2008-04-18 2010-02-16 Reata Pharmaceuticals Inc Natural products including an anti-flammatory pharmacore and methods of use
ES2449396T3 (es) * 2008-07-22 2014-03-19 Trustees Of Dartmouth College Cianoenonas monocíclicas y métodos de uso de las mismas
US8324180B2 (en) * 2009-04-06 2012-12-04 Eisai Inc. Compositions and methods for treating cancer
JO3262B1 (ar) * 2009-04-06 2018-09-16 Otsuka Pharma Co Ltd توليفة من ديسيتابين مع مثبط سيتيدين دي أميناز واستخدامها في علاج السرطان
WO2010118013A1 (en) * 2009-04-06 2010-10-14 Eisai Inc. Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
WO2013151774A1 (en) 2012-04-04 2013-10-10 Halozyme, Inc. Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282921A (en) * 1964-06-04 1966-11-01 Syntex Corp Halo-deoxynucleosides and processes for the preparation thereof
US3721664A (en) * 1970-01-27 1973-03-20 Hoffmann La Roche Preparation of 5-cytosine nucleosides
DE2628202A1 (de) * 1976-06-23 1977-12-29 Max Planck Gesellschaft Verfahren zur herstellung von 2'-substituierten-d-ribofuranosylpurinderivaten
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
FI832884A (fi) * 1982-08-17 1984-02-18 Sandoz Ag Desoxiuridinderivat, deras framstaellningsfoerfaranden och anvaendning som farmaceutiska medel
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4625020A (en) * 1983-11-18 1986-11-25 Bristol-Myers Company Nucleoside process
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US5223608A (en) * 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
EP0339161A1 (en) * 1988-04-01 1989-11-02 Merrell Dow Pharmaceuticals Inc. Novel fluorophosphonate nucleotide derivatives
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
US5175267A (en) * 1990-03-02 1992-12-29 University Of Georgia Research Foundation, Inc. Stereoselective glycosylation of hetercyclic bases
US5426183A (en) * 1992-06-22 1995-06-20 Eli Lilly And Company Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
US5401838A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides

Also Published As

Publication number Publication date
CO4600741A1 (es) 1998-05-08
UA53614C2 (uk) 2003-02-17
AU702588B2 (en) 1999-02-25
TW377356B (en) 1999-12-21
KR100424990B1 (ko) 2004-05-20
DE69524365T2 (de) 2002-08-14
CN1165519A (zh) 1997-11-19
CA2205350A1 (en) 1996-05-30
NO308305B1 (no) 2000-08-28
NZ296712A (en) 1999-01-28
JPH10509170A (ja) 1998-09-08
BG101485A (en) 1998-03-31
SK48597A3 (en) 1997-11-05
KR970707143A (ko) 1997-12-01
PT712860E (pt) 2002-05-31
CZ292013B6 (cs) 2003-07-16
SK283160B6 (sk) 2003-03-04
US5606048A (en) 1997-02-25
SI0712860T1 (en) 2002-04-30
HU219019B (hu) 2001-01-29
WO1996016072A1 (en) 1996-05-30
IL115854A0 (en) 1996-01-31
PL320634A1 (en) 1997-10-13
IL115854A (en) 2000-07-16
NO972214D0 (no) 1997-05-14
MX9703548A (es) 1997-08-30
AR001045A1 (es) 1997-09-24
RO118296B1 (ro) 2003-04-30
DE69524365D1 (de) 2002-01-17
PE50196A1 (es) 1996-11-30
CN1044119C (zh) 1999-07-14
AU4139396A (en) 1996-06-17
DK0712860T3 (da) 2002-03-04
BG62737B1 (bg) 2000-06-30
HUT77926A (hu) 1998-11-30
CZ148197A3 (en) 1997-08-13
EP0712860A3 (en) 1996-09-25
NO972214L (no) 1997-05-14
PL182052B1 (pl) 2001-10-31
MY115183A (en) 2003-04-30
ZA959321B (en) 1997-05-05
CA2205350C (en) 2007-09-04
EP0712860B1 (en) 2001-12-05
BR9509904A (pt) 1997-10-14
ES2164745T3 (es) 2002-03-01
YU49446B (sh) 2006-03-03
EP0712860A2 (en) 1996-05-22
ATE210142T1 (de) 2001-12-15
RU2161622C2 (ru) 2001-01-10

Similar Documents

Publication Publication Date Title
YU70995A (sh) Postupak za prečišćavanje i izdvajanje 2'-deoksi-2',2'-difluoronukleozida
YU74591A (sh) Anti-virusna jedinjenja
HUP0104579A2 (hu) GLP-1 analógok, ezeket tartalmazó gyógyászati készítmények, valamint a vegyületek alkalmazása
NO175981C (no) Analogifremgangsmåte ved fremstilling av pyrimidin-nukleosider og mellomprodukter som anvendes deri
BR9007758A (pt) Processo para inibir o crescimento ou replicacao dos virus da imuno deficiencia humana,compostos,composto intermediario e formulacao farmaceutica para inibir o crescimento ou replicacao do hiv
PT90478A (pt) Processo para a preparacao de derivados da purina e de composicoes farmaceuticas que os contem
BR9808030A (pt) Certos derivados cìclicos de amida de acilaminoácido tio-substituìdos
KR940005656A (ko) 항 바이러스 및 항암 활성을 갖는 2'-데옥시-2', 2'-디플루오로(2,6,8-치환된) 퓨린 뉴클레오시드 및 중간체
EP0219838A3 (en) Carbocyclic purine nucleosides, their production and use
DK624989A (da) Makrolidforbindelser
GB1427572A (en) Acylated arabinofuranosyl cytosines and azacytosines and methods for their preparation
JPS5515445A (en) Introduction of amino-protecting group by microorganism
SE8305538D0 (sv) Polysilylerat kanamycin a eller b som mellanprodukt vid framstellning av derivat av kanamycin a och b
HRP20000733B1 (en) NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS
JPH01246297A (ja) ベータ―２’，２’―ジフルオロヌクレオシド類の製造方法
DE3562623D1 (en) 2'-chloropentostatin, a pharmaceutical composition comprising the compound and a novel microorganism for producing the compound
EE9400143A (et) Bispilokarphappe estri derivaadid, nende valmistamismeetodid ja neid sisaldav farmatseutiline kompositsioon
GB1182488A (en) Improvements in or relating to Nucleotides and the Manufacture thereof
YU94592A (sh) Kompleksne soli hematoporfirina i njegovih derivata i postupak za njihovo dobivanje
Shōji Study on Orientomycin, Identified With D-4-Amino-3-Isoxazolidone Studies on Actinomyces Antibiotics. XXXVII
Manning et al. The Interaction of α-Chymotrypsin with α-N-Carbethoxy-D-and L-tyrosinmethylamide1
Rajagopalan Bacterial chemotherapy: IV. Synthesis of N 4, N 1-diacyl sulphanilamides
Funaki et al. Virocidin, a new antiviral and antibacterial antibiotic
IT1270122B (it) 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono
JPS55145697A (en) Istamycins a or/and b, and their preparation